Skip to content

Clinical trials

Endocarditis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endocarditis Clear all

160 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20053
20063
20074
20085
20093
20102
20115
20123
20135
20144
20153
20169
201710
201810
201911
20207
202112
20229
202310
202411
202512
202613

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed59
Unknown status34
Recruiting29
Terminated13
Not yet recruiting11
Active, not recruiting8
Withdrawn4
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris9
Central Hospital, Nancy, France6
Assistance Publique Hopitaux De Marseille4
Assiut University4
University Hospital, Bordeaux4
University Hospital, Strasbourg, France4
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)3
Fondazione Policlinico Universitario Agostino Gemelli IRCCS3
Jena University Hospital3
Rigshospitalet, Denmark3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endocarditis160
Bacteremia17
Endocarditis, Bacterial13
Sepsis9
Staphylococcal Infections9
Heart Valve Diseases7
Gram-Positive Bacterial Infections5
Acute Kidney Injury4
Disease4
Aortic Valve Disease3

Trials

Showing 51 to 75 of 160. Each trial links to its page on Pharma Observatory.

60 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.